## ACGL: Arch Capital Group Ltd. - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.1% in lower entry zone (4.0-10.0%), top quartile (75th pct) cross-sectional ranking. Short-term MRS_5 (2.9%) confirms momentum alignment. Strong momentum (+6.0% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($92.77)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Analysts Offer Insights on Financial Companies: Arch Capital Group (ACGL) and HASI (HASI)**
- Source: The Globe and Mail | 20251217T190731 | Bullish | Relevance: 100%
- Two financial analysts have issued bullish sentiments on Arch Capital Group (ACGL) and HASI (HASI). Morgan Stanley reiterated a Buy rating on ACGL with a $110.00 price target, while Oppenheimer maintained a Buy rating on HASI with a $50.00 price target, signaling confidence in both companies' potential for upside.

**2. Arch Capital Group (NASDAQ:ACGL) Insider John Pasquesi Sells 203,866 Shares of Stock**
- Source: MarketBeat | 20251216T230749 | Neutral | Relevance: 100%
- John Pasquesi, an insider at Arch Capital Group (NASDAQ:ACGL), recently sold 203,866 shares of the company's stock on December 12th at an average price of $93.90, totaling over $19.14 million. This transaction reduced his stake by 36.72% to 351,356 shares. The company's stock is trading near $95.58, with a market cap of $34.7 billion and a P/E of 8.94, and it recently surpassed quarterly earnings and revenue estimates.

**3. Mizuho initiates Arch Capital stock coverage with Neutral rating**
- Source: Investing.com | 20251215T220728 | Neutral | Relevance: 100%
- Mizuho has initiated coverage on Arch Capital Group (NASDAQ:ACGL) with a Neutral rating and a $95.00 price target, noting the stock is near its 52-week high and their target. While acknowledging Arch Capital's strong past performance and attractive P/E ratio, Mizuho anticipates a slowdown in its excess relative growth and normalization of mortgage insurance results due to market moderating and post-COVID reserve releases. Consequently, Mizuho projects Arch Capital's earnings per share growth to decelerate to single digits in 2025-2027.

**4. Mizuho Upgrades Arch Capital Group (NASDAQ:ACGL) to "Hold"**
- Source: MarketBeat | 20251217T131705 | Neutral | Relevance: 100%
- Mizuho upgraded Arch Capital Group (NASDAQ:ACGL) to a "hold" rating, as reported by Zacks.com. This upgrade comes amidst diverse analyst opinions, with the company currently holding an average "Hold" rating and an average price target of $106.00 among market analysts. The report also highlights recent insider stock sales and institutional investment activity in Arch Capital Group.

**5. Arch Capital Group (NASDAQ:ACGL) Insider Sells $828,696.00 in Stock**
- Source: MarketBeat | 20251216T225604 | Neutral | Relevance: 100%
- Arch Capital Group insider John Pasquesi sold 8,800 shares of company stock for $828,696.00 on December 15th, reducing his position by 2.95%. The sale follows a strong quarterly earnings beat with EPS of $2.77 and revenue of $5.11 billion. Institutional investors own a significant portion of the company, and analysts currently rate the stock as a "Hold" with an average price target of $106.00.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $95 | $0 | 0% |
| 2025-12-02 | Roth Capital | $110 | $125 | -12% |
| 2025-11-17 | Morgan Stanley | $110 | $105 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Neutral |
| 2025-12-02 | Roth Capital | main | Buy |
| 2025-11-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($1.62M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (-0.2%)
- Blackrock Inc.: 8.9% (-1.4%)
- Artisan Partners Lim: 6.5% (-0.8%)
- BAMCO Inc.: 5.2% (-4.9%)
- State Street Corpora: 4.6% (-1.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +6.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.24 elevated, pricing in significant growth expectations. Forward P/E 10.4x stretched relative to 0% growth. Quality metrics strong (margin 21%). Balance sheet: strong liquidity (7513000000.0x), $2.2B free cash flow. Insider selling cluster ($1.6M in 90 days), potential headwind. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.8B |
| Beta | 0.45 |
| 52W Range | $82.45 - $97.40 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.24 |
| Forward P/E | 10.4 |
| Current P/E | 10.4 |
| YoY Growth | 0.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -0.9% to 5.1% (+6.0% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 75th percentile. MRS_5 at 2.9% confirms short-term momentum alignment. AM_20 at 3.0% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.07% (CS: 75) | Strong |
| RSI_14 | 68.0 | Neutral |
| MACD Histogram | 0.26 | Bullish |
| vs SMA20 | 1.030x | Above |
| vs SMA50 | 1.058x | Above |
| vs SMA200 | 1.053x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $95.89
- **Stop Loss:** $92.77 (3.3% risk)
- **Target:** $100.57 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 346
- **Position Value:** $33,177.94
- **Portfolio %:** 33.18%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-10 (Est: $2.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.25 | $2.77 | +22.9% |
| 2025Q2 | $2.30 | $2.58 | +12.2% |
| 2025Q1 | $1.31 | $1.54 | +17.2% |
| 2024Q4 | $1.80 | $2.26 | +25.5% |

---
*RULE-based L3 | 2026-01-07 01:41 | MRS_20*